Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Black elderberry extract is a preparation derived from the cooked or processed berries of the *Sambucus nigra* plant, rich in polyphenolic compounds—especially anthocyanins, flavonoids, and phenolic acids. It is widely marketed and used as an immune support supplement, with purported benefits including antioxidant, anti-inflammatory, antiviral, and other health-promoting effects. However, it is not a single molecular entity, not a receptor or enzyme, nor a classical therapeutic target in drug discovery; it comprises multiple bioactives with a range of biological activities, and its composition can vary greatly depending on plant source, harvesting, and processing methods.
Antioxidant properties via scavenging of free radicals; Modulation of immune signaling pathways (e.g., potential increase in cytokine production); Inhibition of viral adhesion/replication (against influenza and other viruses); Anti-inflammatory signaling
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Black elderberry extract.